☰

Ivan Pasic, Ph.D. - Publications

Affiliations: 
2012 Medical Science University of Toronto, Toronto, ON, Canada 
Area:
Molecular Biology, Oncology, Genetics
Tree Info Grants Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Daher-Reyes G, Kim T, Novitzky-Basso I, Kim KH, Smith A, Stockley T, Capochichi JM, Al-Shaibani Z, Pasic I, Law A, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, et al. Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplantation. PMID 33767401 DOI: 10.1038/s41409-021-01255-4  0.316
2020 Salas MQ, Atenafu EG, Bascom O, Wilson L, Lam W, Law AD, Pasic I, Kim DDH, Michelis FV, Al-Shaibani Z, Gerbitz A, Viswabandya A, Lipton JH, Mattsson J, Alibhai SMH, et al. Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. PMID 32606454 DOI: 10.1038/S41409-020-0979-1  0.309
2020 Alblooshi R, Kanfar S, Lord B, Atenafu EG, Michelis FV, Pasic I, Gerbitz A, Al-Shaibani Z, Viswabandya A, Dong Hwan Kim D, Lam W, Law A, Mattsson J, Kumar R, Lipton JH. Clinical prevalence and outcome of cardiovascular events in the first 100 days post allogeneic HSCT. European Journal of Haematology. PMID 32599663 DOI: 10.1111/Ejh.13482  0.302
2020 Salas MQ, Wilson Lam SC, Pasic I, Gerbitz A, Michelis FV, Kim DDH, Al-Shaibani Z, Howard Lipton J, Mattsson J, Kumar R, Viswabandya A, Datt A. Less is More: Superior GVHD-Free/Relapse-Free Survival with Reduced Intensity Conditioning and Dual T-cell Depletion in AML. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32422253 DOI: 10.1016/J.Bbmt.2020.04.021  0.373
2020 Pasic I, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Mattsson J, Michelis FV. Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation. Annals of Hematology. PMID 32382774 DOI: 10.1007/S00277-020-04033-2  0.364
2019 Pasic I, Da'na W, Lam W, Law A, Lipton JH, Viswabandya A, Kim DD, Thyagu S, Messner HA, Michelis FV. Influence of FLT3-ITD and NPM1 Status on Allogeneic Hematopoietic Cell Transplant Outcomes in Patients with Cytogenetically Normal AML. European Journal of Haematology. PMID 30706524 DOI: 10.1111/Ejh.13216  0.352
2017 Pasic I, Lipton JH. Current approach to the treatment of chronic myeloid leukaemia. Leukemia Research. 55: 65-78. PMID 28135648 DOI: 10.1016/J.Leukres.2017.01.005  0.309
2014 Berlin A, Lalonde E, Sykes J, Zafarana G, Chu KC, Ramnarine VR, Ishkanian A, Sendorek DH, Pasic I, Lam WL, Jurisica I, van der Kwast T, Milosevic M, Boutros PC, Bristow RG. NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer. Oncotarget. 5: 11081-90. PMID 25415046 DOI: 10.18632/Oncotarget.2404  0.362
2012 Porat RM, Pasic I, Shlien A, Gokgoz N, Andrulis I, Wunder JS, Malkin D. Abstract 1447: Investigating susceptibility to sporadic osteosarcoma by genome-wide copy number analysis Cancer Research. 72: 1447-1447. DOI: 10.1158/1538-7445.Am2012-1447  0.561
2011 Porat RM, Pasic I, Shlien A, Golgoz N, Andrulis I, Wunder JS, Malkin D. Abstract 5334: Genome-wide copy number analysis reveals two novel loci for susceptibility to sporadic osteosarcoma Cancer Research. 71: 5334-5334. DOI: 10.1158/1538-7445.Am2011-5334  0.561
2010 Durbin AD, Pasic I, Wong DK, Hannigan GE, Malkin D. The oncogenic and growth-suppressive functions of the integrin-linked kinase are distinguished by JNK1 expression in human cancer cells. Cell Cycle (Georgetown, Tex.). 9: 1951-9. PMID 20495362 DOI: 10.4161/Cc.9.10.11554  0.472
2010 Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN, Novokmet A, Malkin D. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Research. 70: 160-71. PMID 20048075 DOI: 10.1158/0008-5472.Can-09-1902  0.534
2008 Pasic I, Shlien A, Novokmet A, Zhang C, Tabori U, Pinto D, Scherer SW, Malkin D. CONTRIBUTION OF DNA COPY-NUMBER VARIATION (CNV) TO CANCER SUSCEPTIBILITY AND LARGE-SCALE GENOME ALTERATIONS IN OSTEOSARCOMA (OS) Clinical & Investigative Medicine. 31: 19. DOI: 10.25011/CIM.V31I4.4821  0.34
Show low-probability matches.